Research is finding that there is an intricate connection between sleep and inflammation, such that lack of sleep can increase inflammation, noted Andrew McHill, PhD, an assistant professor at Oregon Health and Science University.
Research is finding that changing blood pressure responses from shift work may be due to increased sympathetic activity and that there is an intricate connection between sleep and inflammation, such that lack of sleep can increase inflammation, noted Andrew McHill, PhD, an assistant professor at Oregon Health and Science University.
McHill is an author on 5 abstracts presented at SLEEP 2023 that investigate the impact of sleep patterns and circadian variations on blood pressure and overall health outcomes.
Transcript
Can you elaborate on the interplay between sleep disruption and the body's inflammatory response?
So we know that sleep and inflammation are very intricately connected, such to the point where if you have too much inflammation, it makes it harder to get to sleep or to stay asleep, and if you don't get enough sleep, it can actually increase your inflammation. As far as our findings go, we think it more pertains to the sympathetic activity and increased sympathetic activity with shift work and sleep disruption that is probably changing blood pressure responses when working these shifts.
How do these alterations affect hemodynamic changes observed in blood pressure regulation?
We are very interested in this overnight blood pressure dipping patterns. We know that if your blood pressure dips 10% or greater than what it is during the daytime, that's a very healthy phenotype. However, in some individuals, they don't have this overnight dipping, which has been associated with a whole host of adverse cardiovascular outcomes and premature mortality. So we've been really focusing on this 24-hour blood pressure rhythm, and we find that when individuals transition into shift work or have been working shift work for a long time, they begin to lose this ability to dip their blood pressure at night when they're going to sleep. And so this could be related to a whole host of about adverse outcomes down the road.
Can you provide examples of these adverse outcomes?
Premature mortality, any type of cardiovascular event, heart attack, stroke, it's been tightly associated with all of those 4 outcomes.
I think it's a very exciting time to be in the field of sleep and circadian research, as we are really looking into this kind of personalized approach for sleep hygiene and sleep habits, and looking at novel mechanisms, such as sleep regularity, for improving health. And I think that these mechanisms may be more feasible for an individual. It's easier, I think, probably to tell someone to go to bed at the same time than to tell them to get more sleep, which is a very difficult intervention. By telling someone if you can just try as hard as you can to go to sleep at the same time, I think will be a lot more feasible.
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Transforming Health Care: Insights From Industry Leaders on Health Equity and Policy
September 25th 2023At the National Comprehensive Cancer Network Oncology Policy Summit, prominent figures in the health care industry from diverse organizations emphasized a commitment to advancing health equity and addressing pressing social and health disparities.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Panelists Discuss Insurance Coverage of Opill, OTC Contraceptives During KFF Webinar
September 21st 2023Laurie Sobel, the associate director for women’s health policy at KFF, moderated a panel discussion with Christine Gilroy, MD, MPH; Victoria Nichols, MPH; and Don Downing, RPh, about insurance coverage of FDA-approved Opill and other OTC contraceptives.
Read More
2 Clarke Drive
Cranbury, NJ 08512